Neurol. praxi. 2022;23(4):336-338 | DOI: 10.36290/neu.2021.057

Neuromyelitis optica imitating astrocytoma

MUDr. Kryštof Švub1, MUDr. Kamila Revendová1, 2, doc. MUDr. Ondřej Volný, Ph.D.1, 2, MUDr. Pavel Hradílek, Ph.D.1, 2, MUDr. Olga Zapletalová1, 2, RNDr. Pavlína Kušnierová, Ph.D.3, 4, prof. MUDr. Michal Bar, Ph.D.1, 2
1 Neurologická klinika Fakultní nemocnice Ostrava
2 Katedra klinických neurověd, Lékařská fakulta Ostravské univerzity, Ostrava
3 Ústav laboratorní diagnostiky, Fakultní nemocnice Ostrava
4 Katedra biomedicínských oborů, Lékařská fakulta, Ostravská univerzita, Ostrava

Our case report presents a 23-year-old young female who was admitted to the Department of Neurology at the University Hospital Ostrava for further investigation of progressive central quadruparesis and a finding of an elongated spindle-shaped lesion with affection of the spinal gray matter in the cervical and rostral thoracic spinal segments on a T2 weighted magnetic resonance imaging. In a differential diagnosis process of a patient with an extensive spinal cord hypersignal lesion on T2 weighted images it is important to take into our diagnostic considerations a diagnosis from the neuromyelitis optica spectrum disorders, and both the anti-aquaporin and anti-myelin oligodendrocyte glycoprotein antibodies should be tested from the serum, so that these patients do not have to undergo a spinal cord surgery due to a misdiagnosis of spinal cord tumour.

Keywords: AQP4-IgG, MOG-IgG, Wingerchuk's diagnostic criteria, myelitis.

Received: June 6, 2021; Revised: July 27, 2021; Accepted: August 10, 2021; Prepublished online: August 10, 2021; Published: August 30, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Švub K, Revendová K, Volný O, Hradílek P, Zapletalová O, Kušnierová P, Bar M. Neuromyelitis optica imitating astrocytoma. Neurol. praxi. 2022;23(4):336-338. doi: 10.36290/neu.2021.057.
Download citation

References

  1. Abboud H, Petrak A, Mealy M, et al. Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma Exchange. Mult scler. 2016;22(2):185-192. Go to original source... Go to PubMed...
  2. Havrdová E. Klinický doporučený postup pro diagnostiku a léčbu roztroušené sklerózy a neuromyelitis optica a onemocnění jejího širšího spektra [internet]. 2020 [cited 2021-05-01]. Available from WWW: https://www.czech-neuro.cz/pro-odborniky/doporucene-postupy/klinicke-standardy/klinicky-doporuceny-postup-pro-diagnostiku-a-lecbu-roztrousene-sklerozy-a-neuromyelitis-optica-a-onemocneni-jejiho-sirsiho-spektra/.
  3. Hartung HP, Graf J, Aktas O, Mares J, Barnett MH. Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and change. Current Opinion in Neurology. 2019;32(3):327-337. Go to original source... Go to PubMed...
  4. Hradílek P. Terapie relapsů u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N. 2020;83/116(Suppl 1):58-61. Go to original source...
  5. Huda S, Whittam D, Bhojak M, et al. Neuromyelitis optica spectrum disorders. Clinical Medicine. 2019;19(2): 169. Go to original source... Go to PubMed...
  6. Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clinical & Experimental Immunology. 2014;176(2):149-164. Go to original source... Go to PubMed...
  7. Krejsek J. Neuromyelitis optica - imunopatogenetické mechanismy. Cesk Slov Neurol N. 2020;83/116(Suppl 1): 11-14. Go to original source...
  8. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-12. Go to original source... Go to PubMed...
  9. Libertínová J. Epidemiologie, klinický obraz a průběh onemocnění u neuromyelitis optica a onemocnění jejího širšího spektra. Cesk Slov Neurol N. 2020;83/116(Suppl 1):15-19. Go to original source...
  10. Nytrová P, Horáková D. Neuromyelitis optica. Cesk Slov Neurol N. 2015;78/111(2):130-138. Go to original source...
  11. Nytrová P. Historie neuromyelitis optica a onemocnění jejího širšího spektra, vývoj diagnostických kritérií. Cesk Slov Neurol N. 2020;83/116(Suppl 1):5-10. Go to original source...
  12. Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012;11:535-544. Go to original source... Go to PubMed...
  13. Růžička E, Šonka K, Marusič P, a kol. Neurologie. Triton 2019: 288 s.
  14. Štětkářová I, a kol. Moderní farmakoterapie, 2. rozšířené vydání. Praha: Maxdorf 2017: 165-168 s.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.